- Article
Comparing the Efficacy of Two Generations of EGFR-TKIs: An Integrated Drug–Disease Mechanistic Model Approach in EGFR-Mutated Lung Adenocarcinoma
- Hippolyte Darré,
- Perrine Masson,
- Arnaud Nativel,
- Laura Villain,
- Diane Lefaudeux,
- Claire Couty,
- Bastien Martin,
- Evgueni Jacob,
- Michaël Duruisseaux and
- Adèle L’Hostis
- + 2 authors
Mutationsin epidermal growth factor receptor (EGFR) are found in approximately 48% of Asian and 19% of Western patients with lung adenocarcinoma (LUAD), leading to aggressive tumor growth. While tyrosine kinase inhibitors (TKIs) like gefitinib and os...

